Information for activists, patients, health workers & researchers working to end tuberculosis
Website of the Global Tuberculosis Community Advisory Board
By Akihide Anzai Published: Nov. 28, 2017, 7:34 p.m.· Tags: Drug-resistant TB, Treatment, Access, Pharma industry
TOKYO -- With tuberculosis killing 1.67 million people every year, Otsuka Pharmaceutical is expediting deliveries of a new drug called Delamanid to India and other developing countries that are desperate for a cure.
Read More →
Page 1 of 1 · Total posts: 1
